TY  - BOOK
AU  - Mackness,B.
ED  - International Conference on Paraoxonases
TI  - The paraoxonases: their role in disease development and xenobiotic metabolism 
T2  - Proteins and cell regulation
SN  - 1402065604
AV  - QU136 .I594 2008
PY  - 2007///
CY  - Dordrecht, London
PB  - Springer
KW  - Paraoxonase
KW  - Congresses
KW  - Aryldialkylphosphatase
N1  - Selected conference papers; Contributors			; Preface			; PART 1 The Bert La Du Memorial Lecture			; 	Paraoxonases: An Historical Perspective; 			; 	C.E. Furlong; 			; PART 2 PONs and Atherosclerosis			; 	1. Glucose Inactivates Paraoxonase 1 (PON1) and Displaces it from High Density Lipoprotein (HDL) to a Free PON1 Form; 			; 	Mira Rosenblat, Orly Sapir and Michael Aviram; 			; 	2. Paraoxonase-1 and Cardiovascular Disease; 			; 	B. Mackness and M.I. Mackness; 			; 	3. Oxidative Stress and Antioxidants and PON 1 in Health and Disease; 			; 	Eser Yildirim Sozmen, Ferhan Girgin Sagin, Meral Kayikcioglu and Bulent Sozmen; 			; 	4. D-4F Increases Paraoxonase 1 Activity in HDL; 			; 	Greg Hough; 			; 	5. Paraoxonase 1 (PON1), A Junction Between the Metabolisms of Homocysteine and Lipids; 			; 	H. Jakubowski; 			; 	6. The Role of PON2 and PON3 in Atherosclerosis and Related Traits; 			; 	N. Bourquard, D.M. Shih, C.J. Ng, N. Villa-Garcia, K. Nakamura, D.A. Stoltz, E. Ozer, V. Grijalva, N. Rozengurt, S. Y. Hama, J. Zabner, M. Navab, A.M. Fogelman and S.T. Reddy; 			; 	7. Paraoxonase 1 and Postprandial Lipemia; 			; 	A. Alipour, B. Coll, A.P. Rietveld, Marsillach, J. Camps, J. Joven, J.W.F. Elte and M. Castro Cabezas; 			; 	8. PON1 Genotypes and Coronary Heart Disease; 			; 	M. Roest and H.A.M. Voorbij; 			; PART 3 PON1 Structure			; 	9. Human Paraoxonase I: A Potential Bioscavenger of Organophosphorus Nerve Agents; 			; 	David T. Yeung, David E. Lenz and Douglas M. Cerasoli; 			; 	10. Stabilisation of Active Form of Natural Human PON1 Requires HPBP; 			; 	D. Rochu, E. Chabriere, M. Elias, F. Renault, C. Clery-Barraud and P. Masson; 			; PART 4 PONs in Disease other than Atherosclerosis			; 	11. Paraoxonase-1 in Chronic Liver Diseases, Neurological Diseases and HIV Infection; 			; 	J. Marsillach, S. Parra, N. Ferre, B. Coll, C. Alonso-Villaverde, J. Joven and J. Camps; 			; 	12. Age-Related Alterations in PON1; 			; 	I. Seres, T. Fulop, G. Paragh and A. Khalil; 			; PART 5 PON and Toxicology			; 	13. Paraoxonase (PON1) and Organophosphate Toxicity; 			; 	L.G. Costa, T.B. Cole, K.L. Jansen and C.E. Furlong; 			; 	14. Implications of Paraoxonase-1 (PON1) Activity and Polymorphisms on Biochemical and Clinical Outcomes in Workers Exposed to Pesticides; 			; 	A.F. Hernández, O. López, G. Pena, J.L. Serrano, T. Parrón, L. Rodrigo, F. Gil and A. Pla; 			; PART 6 PON-Genetics and Regulation			; 	15. Transcriptional Regulation of the Paraoxonase Genes; 			; 	S. P. Deakin and R. W. James; 			; 	16. Effect of Lipid Lowering Medications on PON 1; 			; 	G. Paragh, M. Harangi and L Seres; 			; 	17. The Functional Consequences of Polymorphisms in the Human PON1 Gene; 			; 	C.E. Furlong, R.J Richter, W.-F. Li, V.H. Brophy, C. Carlson, M. Rieder, D. Nickerson, L.G. Costa, J. Ranchalis, A.J. Lusis, D.M. Shih, A. Tward and G.P. Jarvik; 			; 	18. Dietary Modulation of Paraoxonase-1 Activity and Concentration in Humans; 			; 	C. Dalgård; 			; PART 7 PONs Biochemistry			; 	19. PONs' Natural Substrates – The Key for their Physiological Roles; 			; 	D.I. Draganov and J.F. Teiber; 			; 	20. Paraoxonases, Quorum Sensing, and Pseudomonas aeruginosa; 			; 	D.A. Stoltz, E.A. Ozer and J. Zabner; 			; Index
N2  - Features a distillation of the plenary lectures presented at the International Conference on Paraoxonases, held in Hajduszoboszlo, Hungary, in September 2006. This book offers a review of paraoxonase research
ER  -